Charlotte Bloodworth and Marcia Short describe how nurses can use these advances to improve support for people living with the disease
Over the past decade, many novel treatments for myeloma have been developed and are now in use. The limited treatments delivered previously were chemotherapy based and either intensive, such as the autologous transplant, or gentle oral drugs, such as low-dose melphalan and dexamethasone. In addition to treatment developments, diagnostics have also evolved.
This article explores three important aspects of modern myeloma care: diagnostics, treatments and survivorship. It discusses how nurses can improve their input in each area to provide more effective support for people living longer with the disease.
Cancer Nursing Practice. 14, 3, 33-37. doi: 10.7748/cnp.14.3.33.e1172
Correspondencecharlotte.bloodworth@wales.nhs.uk
Peer reviewThis article has been subject to double blind peer review
Conflict of interestNone declared
Received: 23 December 2014
Accepted: 16 February 2015
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more